EGFR 20外显子插入突变非小细胞肺癌规范化诊疗中国专家共识（2023版）

With the development of precision diagnosis and treatment for non-small cell lung cancer (NSCLC), the epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations, as a rare subset of EGFR mutaions, have gradually attracted attention recently. The heterogeneity of EGFR ex20ins mutat...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial board of Chinese Journal of Lung Cancer 2023
Materias:
Expert Consensus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273153/
https://www.ncbi.nlm.nih.gov/pubmed/37316442
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.10

Ejemplares similares

Ejemplares similares